Risk factor
Strong & resilient to price shocks
Profitability factor
Strong margins and returns
About
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance,...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/E
Target Price
The average target price of SOLV is 93 and suggests 39% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell